Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
US FDA Review Of Akebia’s Vafseo Informed By Roxadustat, Daprodustat Safety Concerns
Sep 13 2024
•
By
Sue Sutter
The FDA's review of Vafseo included a close look at the safety issues flagged for two other drugs. • Source: Shutterstock
More from Drug Review Profiles
More from Product Reviews